Varsha  Jain

Dr. Varsha Jain

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2018 in Cancers
Verified
Journal Article
Open access
PDF file
VJVarsha Jain
Varsha Jain
ABAbigail Berman
Abigail Berman
Radiation therapy is a major treatment modality for management of non-small cell lung cancer. Radiation pneumonitis is a dose limiting toxicity of radiotherapy, affecting its therapeutic ratio. This review presents patient and treatment related factors associated with the development of radiation pneumonitis. Research focusing on reducing the incidence of radiation pneumonitis by using information about lung ventilation, imaging-based biomarkers as well as normal tissue complication models is discussed. Recent advances in our understanding of molecular mechanisms underlying lung injury has led to the development of several targeted interventions, which are also explored in this review.

17 June 2010 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
WWWen‐Chau Wu
Wen‐Chau Wu
VJVarsha Jain
Varsha Jain
CLCheng Li
Cheng Li
MGMariel Giannetta
Mariel Giannetta
HHHallam Hurt
Hallam Hurt
DWDanny J. J. Wang
Danny J. J. Wang
A time‐efficient method is described for in vivo venous blood T1 measurement using multiphase inversion‐recovery‐prepared balanced steady‐state free precession imaging. Computer simulations and validation experiments using a flow phantom were carried out to demonstrate the accuracy of the proposed method for measuring blood T1 by taking advantage of the continuous inflow of fresh blood with longitudinal magnetization undisturbed by previous radiofrequency pulses. In vivo measurement of venous blood T1 in the sagittal sinus was carried out in 26 healthy children and adults aged 7–39 years. The measured venous blood T1 values decreased with age as a whole (P = 0.006) and were higher in females than males (P = 0.013), matching the expected developmental changes and gender differences in human hematocrit level. The estimated mean blood T1 values were highly correlated with normal hematocrit levels across age and gender groups (Spearman's r = 0.93, P = 0.008). The longitudinal repeatability of this technique was 4.0% as measured by the within‐subject coefficient of variation. The proposed multiphase inversion recovery‐prepared balanced steady‐state free precession imaging method is a feasible technique for fast (<1 min) and reliable in vivo venous blood T1 measurement and may serve as an index of hematocrit level in individual subjects. Magn Reson Med, 2010.

1 March 2020 in International Journal of Particle Therapy
Verified
Journal Article
Open access
VJVarsha Jain
Varsha Jain
PIPeyton Irmen
Peyton Irmen
SOShannon O'REilly
Shannon O'REilly
JVJennifer H. Vogel
Jennifer H. Vogel
LLLiyong Lin
Liyong Lin
ALAlexander Lin
Alexander Lin
Purpose: There has been a recent epidemic of human papillomavirus (HPV)–positive oropharyngeal cancer, accounting for 70% to 80% of diagnosed cases. These patients have an overall favorabl...

4 September 2019 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
VJVarsha Jain
Varsha Jain
SVSriram Venigalla
Sriram Venigalla
RSRonnie A. Sebro
Ronnie A. Sebro
GKGiorgos Karakousis
Giorgos Karakousis
RWRobert J. Wilson
Robert J. Wilson
JSJacob E Shabason
Jacob E Shabason
Background: Numerous studies across a variety of malignancies have demonstrated that health insurance status is associated with differences in clinical presentation, type of treatments received, and survival. The effect of insurance status on the management of soft tissue sarcoma is unknown. We assessed the association of insurance on (a) stage at diagnosis, (b) receipt of neoadjuvant/adjuvant radiation therapy, and (c) overall survival (OS) in patients with soft tissue sarcoma.Methods: The study cohort was identified from the National Cancer Database (NCDB) and consisted of patients with stage I‐IV soft tissue sarcoma of various histologies diagnosed from 2004 to 2015. The patients were stratified by age (<65 and ≥65 years) and by insurance status (commercial, Medicare, Medicaid and uninsured). Using multivariable logistic regression analysis, we evaluated the association between insurance status and (a) stage at diagnosis (Stage I‐III vs IV), and (b) receipt of neoadjuvant/adjuvant radiation therapy in patients with locally advanced disease. The association of insurance status on OS was assessed using Kaplan‐Meier and multivariable Cox proportional hazards analyses. A propensity score matched survival analysis was performed to account for measured confounders.Results: 49 754 patients were identified of whom 23 677 (48%) had commercial insurance, 20 867 (42%) had Medicare, 3229 (6%) had Medicaid, and 1981 (4%) were uninsured. In patients <65 years, those with Medicaid (OR = 1.74, 95% CI: 1.57‐1.93, P < .001) and the uninsured (OR = 1.71, 95% CI: 1.51‐1.94, P < .001) were more likely to present with stage IV vs Stage I‐III disease. Furthermore, among patients with locally advanced disease treated with limb sparing surgery, those with Medicaid (OR = 0.87, 95% CI: 0.77‐ 0.98, P = .021) and the uninsured (OR = 0.73, 95% CI: 0.63‐0.85, P < .001) were less likely to receive neoadjuvant or adjuvant radiotherapy as compared to those with commercial insurance. Lastly, having Medicaid (HR = 1.26, 95% CI: 1.17‐1.34, P < .001) and no insurance (HR = 1.30, 95% CI: 1.20‐1.41, P < .001) was associated with worse OS compared to having commercial insurance, a finding which remained significant after propensity score matching. In contrast, in patients ≥65 years, there were no statistically significant differences between those with Medicare and commercial insurance with regards to disease presentation, receipt of radiotherapy, or survival.Conclusions: In a large modern cohort identified from the NCDB, commercial insurance status in patients <65 years was associated early diagnosis, receipt of neoadjuvant/adjuvant radiation therapy, and overall survival for patients with soft tissue sarcoma. Further efforts are warranted to understand disparities in care based on health insurance in the United States.

1 November 2018 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Open access
VJVarsha Jain
Varsha Jain
Arjen Van der SchaafArjen Van der Schaaf
Arjen Van der Schaaf
MFM. Frick
M. Frick
ADA. Doucette
A. Doucette
CSCharles Simone
Charles Simone
ABAbigail Berman
Abigail Berman